Stern, N.; Gacs, A.; Tátrai, E.; Flachner, B.; Hajdú, I.; Dobi, K.; Bágyi, I.; Dormán, G.; Lőrincz, Z.; Cseh, S.;
et al. Dual Inhibitors of AChE and BACE-1 for Reducing Aβ in Alzheimer’s Disease: From In Silico to In Vivo. Int. J. Mol. Sci. 2022, 23, 13098.
https://doi.org/10.3390/ijms232113098
AMA Style
Stern N, Gacs A, Tátrai E, Flachner B, Hajdú I, Dobi K, Bágyi I, Dormán G, Lőrincz Z, Cseh S,
et al. Dual Inhibitors of AChE and BACE-1 for Reducing Aβ in Alzheimer’s Disease: From In Silico to In Vivo. International Journal of Molecular Sciences. 2022; 23(21):13098.
https://doi.org/10.3390/ijms232113098
Chicago/Turabian Style
Stern, Noa, Alexandra Gacs, Enikő Tátrai, Beáta Flachner, István Hajdú, Krisztina Dobi, István Bágyi, György Dormán, Zsolt Lőrincz, Sándor Cseh,
and et al. 2022. "Dual Inhibitors of AChE and BACE-1 for Reducing Aβ in Alzheimer’s Disease: From In Silico to In Vivo" International Journal of Molecular Sciences 23, no. 21: 13098.
https://doi.org/10.3390/ijms232113098
APA Style
Stern, N., Gacs, A., Tátrai, E., Flachner, B., Hajdú, I., Dobi, K., Bágyi, I., Dormán, G., LÅ‘rincz, Z., Cseh, S., KÃgyós, A., Tóvári, J., & Goldblum, A.
(2022). Dual Inhibitors of AChE and BACE-1 for Reducing Aβ in Alzheimer’s Disease: From In Silico to In Vivo. International Journal of Molecular Sciences, 23(21), 13098.
https://doi.org/10.3390/ijms232113098